Chirurgische Adipositas-Behandlung – Notwendigkeit oder einfacher Weg zur Gewichtsabnahme?

The determination of eligibility for bariatric surgery is founded upon a comprehensive clinical assessment that incorporates multiple factors, including the patient’s biological age, peak recorded body mass index (BMI), and the presence of obesity-related comorbidities. Typically, this surgical intervention is recommended for adult patients aged 18–65 years whose BMI reaches or exceeds 40 kg/m². For individuals with a BMI ranging from 35.0 to 39.9 kg/m², the procedure may be considered if there is substantiated medical evidence suggesting that surgical weight reduction will yield significant health improvements—particularly in cases complicated by concurrent conditions such as insulin-resistant type 2 diabetes mellitus, cardiovascular disorders (e.g., hypertension, atherosclerosis), or obstructive sleep apnea syndrome. In exceptional circumstances, patients with a BMI of 30.0–34.9 kg/m² may qualify for surgery if hyperglycemia remains refractory to conventional pharmacological treatments and the risk of metabolic complications is substantial. For minors under the age of 18, bariatric surgery is contemplated only after the patient has attained sufficient physical and psychological maturity, coupled with the exhaustion of all conservative treatment modalities (dietary modification, physical activity, behavioral therapy) over a minimum duration of six months. In patients older than 65 years, bariatric procedures are primarily reserved for cases of morbid obesity (BMI > 40 kg/m²), provided that the anticipated health benefits substantially outweigh the operative risks and the patient’s overall health status—including biological age—does not pose a contraindication (as outlined in the guidelines of the Polish Society for Bariatric Surgery, Budzyński et al., 2017).

Eligibility for surgical interventions targeting morbid obesity is contingent upon a rigorous assessment of medical contraindications, which are systematically categorized into absolute and relative limitations. Absolute contraindications encompass clinical conditions that preclude operative treatment due to prohibitive perioperative risks or the absence of prospective health benefits—these include advanced malignant neoplasms in terminal stages, HIV infection progressing to AIDS, acute cardiovascular events (e.g., recent myocardial infarction), and severe respiratory failure secondary to chronic obstructive pulmonary disease. Additionally, endocrine pathologies serving as the primary etiology of obesity (e.g., Cushing’s syndrome), profound coagulopathies (such as hemophilia), unstable psychiatric disorders resistant to pharmacological stabilization (including psychotic spectrum illnesses and major depressive episodes), and significant cognitive impairments that preclude informed consent constitute unequivocal exclusions. Pregnancy at any gestational stage, lactation, and intended conception within the subsequent twelve-month period are likewise categorical disqualifiers. Relative contraindications pertain to individuals with a body mass index ranging from 35.0 to 39.9 kg/m² who lack concomitant metabolic comorbidities (e.g., type 2 diabetes mellitus), as well as those exhibiting preoperative weight gain, diminished physical performance capacity (a predictor of suboptimal postoperative prognosis), active peptic ulcer disease, or portal hypertension associated with hepatic cirrhosis. Oncological patients may only be considered for bariatric procedures following documented complete remission of malignancy, a determination that must be validated through multidisciplinary consultation (in accordance with guidelines established by Budzyński et al., 2017).

Distinct surgical approaches for weight reduction are characterized by unique mechanisms of action that influence metabolic processes and gastrointestinal physiology in different ways. Each available procedure presents a specific profile of therapeutic benefits, potential complications, and medical eligibility criteria, making the personalized selection of the most suitable method an indispensable component of effective and safe treatment for patients struggling with morbid obesity.

This surgical intervention involves permanently reducing the stomach’s capacity while rerouting the digestive pathway through the small intestine, thereby substantially limiting the body’s ability to absorb caloric content and essential micro- and macronutrients. Although the procedure is technically complex and more invasive than alternative bariatric techniques, it demonstrates exceptional long-term efficacy in achieving sustained weight loss among individuals with morbid obesity or concurrent metabolic disorders.

This well-established bariatric intervention, referred to as sleeve gastrectomy or *vertical gastrectomy*, involves the permanent excision of approximately 75–80% of the stomach’s volume along its greater curvature, resulting in the formation of a narrow, tubular "sleeve." The procedure induces physiological appetite suppression by reducing ghrelin secretion—the hormone responsible for hunger stimulation—while simultaneously imposing mechanical restrictions on gastric capacity. Consequently, patients achieve substantial and enduring weight loss without compromising the absorption of essential nutrients.

This minimally invasive procedure involves the surgical placement of a flexible, adjustable silicone band around the proximal portion of the stomach, thereby mechanically constricting the volume of ingested food. While the technique is classified as a reversible bariatric intervention, its long-term efficacy in achieving sustained weight loss remains inferior when compared to alternative surgical approaches—such as sleeve gastrectomy or gastric bypass procedures. Notably, due to a high incidence of delayed postoperative complications—including band slippage, gastric wall erosion, and inadequate weight maintenance—the procedure has seen a declining trend in clinical adoption, as evidenced by meta-analytical data, including the 2018 study by Razak and colleagues.

This represents the most intricate and surgically demanding bariatric intervention, entailing profound anatomical and physiological alterations to the digestive system. Unlike conventional gastric bypass procedures, it involves the exclusion of a substantially greater segment of the small intestine from the digestive process, thereby achieving more pronounced and sustained weight loss outcomes. The operation also incorporates a partial gastrectomy, though the residual stomach capacity post-surgery ranges between 300 and 500 milliliters—significantly larger than the 30–50 milliliters typical of standard bypass procedures. Owing to an elevated risk of complications—particularly chronic deficiencies in proteins, vitamins, and trace elements—this technique is now reserved primarily for patients with severe obesity (Binda et al., 2013). Alternative modalities such as laparoscopic gastric plication or intragastric balloon placement lack robust long-term efficacy data, limiting their adoption in clinical practice (Budzyński et al., 2017).

The preoperative preparation phase for bariatric surgery constitutes a foundational component of the entire therapeutic process, designed not only to mitigate potential complications but also to enhance the clinical efficacy of the intervention. This stage necessitates a thorough medical diagnostic workup, encompassing both laboratory investigations and multidisciplinary specialist consultations. Concurrently, the patient is required to participate in a structured educational program aimed at disseminating accurate, evidence-based information regarding the technical aspects of the surgery, potential health implications, and anticipated therapeutic benefits. An equally critical element of preparation involves psychological or psychiatric evaluation, intended to identify any contraindications of a mental health nature and to equip the patient with coping strategies for the emotional and behavioral adjustments that frequently accompany the postoperative period. Empirical research consistently demonstrates that a comprehensive, multidisciplinary approach to patient preparation significantly improves the likelihood of sustained weight loss and long-term quality-of-life improvements (Budzyński A. et al., 2017; current guidelines from the American Society for Metabolic and Bariatric Surgery).

Undergoing bariatric surgery initiates a multifaceted transformation process designed not solely for weight reduction but also for the sustained enhancement of metabolic health, physical fitness, and psychological well-being. In the immediate postoperative period, adherence to a meticulously tailored nutritional regimen—structured into progressive phases of increasing dietary complexity—is imperative. The initial stage mandates a liquid-based diet, comprising clear broths, protein-enriched beverages, and strained soups, to minimize gastrointestinal stress and facilitate tissue repair. Within several days, contingent upon individual tolerance, the dietary protocol may expand to include semi-solid foods such as puréed vegetables, smooth dairy products (e.g., low-fat yogurt or custards), and blended fruit preparations. Subsequent phases involve a gradual transition to solid foods, with an emphasis on high-quality protein sources (e.g., lean meats, fish, eggs, legumes) essential for preserving lean muscle mass and preventing micronutrient deficiencies. The specific dietary guidelines, however, are contingent upon multiple variables, including the surgical technique employed (e.g., sleeve gastrectomy versus gastric bypass), the patient’s physiological response to the intervention, and the pace of recovery—all of which are monitored by a multidisciplinary care team. Concurrently with dietary modifications, a progressively intensified physical activity regimen must be implemented, beginning with low-impact exercises (e.g., brief walks, breathing techniques) and advancing—upon medical clearance—to more vigorous activities (resistance training, cardiovascular workouts, swimming) to optimize body composition and mitigate weight regain. Equally critical is the integration of psychological support, encompassing both one-on-one counseling and participation in peer support groups, as adaptive challenges, alterations in body image perception, and concerns regarding long-term outcome maintenance can significantly impact emotional stability—a phenomenon corroborated by research conducted by Sierżantowicz et al. (2022) on the prolonged effects of bariatric surgery.

Surgical interventions for the management of severe obesity demonstrate substantially greater efficacy when compared to conventional non-invasive approaches, yielding a comprehensive spectrum of well-documented health benefits for affected individuals. Bariatric procedures facilitate remarkable weight reduction, frequently amounting to 20–50% of excess body mass within the initial twenty-four-month period following the operation. This pronounced loss of weight subsequently translates into significant improvements across multiple comorbid conditions, most notably including complete remission of type 2 diabetes mellitus in a substantial proportion of surgical patients, optimization of lipid metabolism profiles, stabilization of blood pressure parameters, and enhanced peripheral tissue sensitivity to insulin. Furthermore, these surgical interventions markedly diminish the risk of developing cardiovascular pathologies, a consequence primarily attributable to reduced hemodynamic strain on the circulatory system and decreased myocardial oxygen demand. Postoperative patients frequently report subjective enhancements in overall quality of life metrics, elevated daily energy levels, and improved sleep architecture—particular benefits that assume heightened importance in the context of obstructive sleep apnea syndrome management. Additional advantageous outcomes encompass alleviation of musculoskeletal pain syndromes, mitigation of gastroesophageal reflux disease symptoms, and enhancement of pulmonary ventilatory-diffusive capacity. It is nevertheless critical to acknowledge that a subset of operated individuals may experience weight regain over time, potentially approaching pre-surgical body mass within a five-to-ten-year postoperative window. The sustained long-term success of bariatric therapy remains contingent upon the patient's rigorous adherence to prescribed lifestyle modifications, including maintenance of a calorie-restricted balanced diet and engagement in regular moderate-intensity physical activity. Structured multidisciplinary postoperative care—incorporating psychological counseling and nutritional guidance—plays an indispensable role in consolidating achieved therapeutic outcomes, as substantiated by research conducted under the direction of D.E. Arterburn and colleagues published in 2020.